A Study of Mosliciguat in PH-ILD

NCT06635850 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

135

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Hypertension
Interstitial Lung Disease
Lung Diseases
Vascular Diseases
Cardiovascular Diseases
Fibrosis

Interventions

DRUG: Mosliciguat
DEVICE: Dry Powder Inhaler
DRUG: Placebo

Sponsor

Pulmovant, Inc.